The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So to your initial question, could a more precise stimulation method like optogenetics help in this setting? In principle, it could, because that if you would target the light sensitivity to just the right kind of cell, let's say cell x that goes from point A to point B that you know causes symptom relief of a particular kind, then you're in business.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.